Lilly is the third company to partner with Sangamo on STAC-BBB after Astellas Gene Therapies, which paid $20 million upfront ...

Sangamo Therapeutics (SGMO) announced it has entered into a license agreement with Eli Lilly (LLY), allowing Lilly to leverage Sangamo’s novel ...

Binding of miR-3036-5p to CYP18A1 can be prevented by an A-to-I RNA editing, thus elevating CYP18A1 expression, decreasing 20E titer, and finally regulating the wing dimorphism of offspring in aphid.

H.C. Wainwright keeps a Buy rating on Tenaya Therapeutics (TNYA) with a $5 price target after the company presented an interim update from the ...

Recent advancements in biosensing technologies have paved the way for revolutionary diagnostic and treatment methods that prioritize speed, accuracy, and ...

Horizontal gene transfer (HGT) is the movement of genetic material from one organism to another. In this article, we will ...

Cell-free systems, which can express an easily detectable protein with a DNA or mRNA template without constraints of living ...

Detailed price information for Tenaya Therapeutics Inc (TNYA-Q) from The Globe and Mail including charting and trades.

ABSTRACT: Diabetes mellitus (DM) is associated with increased bone fragility despite normal or elevated bone mineral density, partially due to the accumulation of advanced glycation end products (AGEs ...

Cellular reprogramming is an intrinsic evolutionary trait to constantly promote adaptations that confer survival advantage. It is also more frequent during development when organs are being formed and ...

Metastasis-suppressor genes are identified by their reduced expression in highly metastatic, compared with tumorigenic but poorly or non-metastatic, tumour cells. Following re-expression of a ...